All In MedTech

FDA Clearance Tracker · P150031-S055

Vercise S8 Adapter

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 6, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 6, 2023

Approved

Time to decision

173 days

Received Mar 17, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150031-S055
Device name
Vercise S8 Adapter
Applicant location
Valencia, CA
Received
Mar 17, 2023
Decided
Sep 6, 2023
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150031

Device type

Device class
Class III

Every decision under product code NHL

FDA's approval statement

As written in FDA's record.

Approval for the Vercise Adapter S8 and the addition of the use with Abbott Lead models (6170, 6171, 6172, 6173, 6178, 6179, 6180, and 6181) to the Vercise Neural Navigator 5 (VNN5) software.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.